FANCD2 but not FANCA promotes cellular resistance to type II topoisomerase poisons. [electronic resource]
Producer: 20110527Description: 86-93 p. digitalISSN:- 1872-7980
- Antineoplastic Agents -- pharmacology
- Cell Line
- DNA Breaks, Double-Stranded -- drug effects
- DNA Repair -- drug effects
- DNA Topoisomerases, Type II -- metabolism
- Drug Resistance, Neoplasm -- physiology
- Etoposide -- pharmacology
- Fanconi Anemia Complementation Group A Protein -- metabolism
- Fanconi Anemia Complementation Group D2 Protein -- metabolism
- Fluorescent Antibody Technique
- Humans
- RNA Interference
- Signal Transduction -- drug effects
- Topoisomerase II Inhibitors -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.